Progesterone increases tissue factor gene expression, procoagulant activity, and invasion in the breast cancer cell line ZR-75-1

被引:44
作者
Kato, S
Pinto, M
Carvajal, A
Espinoza, N
Monso, C
Sadarangani, A
Villalon, M
Brosens, JJ
White, JO
Richer, JK
Horwitz, KB
Owen, GI
机构
[1] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Unidad Reprod & Desarrollo, Santiago, Chile
[2] Pontificia Univ Catolica Chile, Fac Med, Dept Obstet & Ginecol, Santiago, Chile
[3] Hammersmith Hosp, Imperial Coll London, Inst Reprod & Dev Biol, London W12 0NN, England
[4] Univ Colorado, Hlth Sci Ctr, Dept Med, Div Endocrinol, Denver, CO 80262 USA
关键词
D O I
10.1210/jc.2004-0857
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Progesterone in hormonal preparations increases the incidence of breast cancer. Tissue factor (TF), the initiator of the extrinsic coagulation pathway, is associated with metastasis in a wide variety of cancers. We demonstrate herein that TF mRNA and protein are up-regulated by progesterone in the breast cancer cell line ZR-75. Epidermal growth factor, also associated with increased breast cancer risk, did not regulate TF. The increase in TF is both rapid and transient; increasing after 6 h, reaching a maximum at 24 h, before decreasing to basal levels at 72 h. Sucrose gradient experiments demonstrated that TF is located in the heavy fraction of the plasma membrane, although caveolin-1 is not expressed in ZR-75. To understand the physiological implications of an increase in TF, we performed coagulation and invasion assays. An increase in TF corresponded to an increase in procoagulant activity. Furthermore, progesterone increased the invasion of ZR-75 cells through a matrigel, an effect that was blocked by an antibody against TF. Because TF expression is associated with an enhanced risk of metastasis, we postulate that the progesterone-dependent up-regulation of TF provides a survival advantage to burgeoning breast cancer cells and may contribute to the increased risk of cancer associated with combined hormone replacement therapy.
引用
收藏
页码:1181 / 1188
页数:8
相关论文
共 50 条
[1]   Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor [J].
Abe, K ;
Shoji, M ;
Chen, J ;
Bierhaus, A ;
Danave, I ;
Micko, C ;
Casper, K ;
Dillehay, DL ;
Nawroth, PP ;
Rickles, FR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (15) :8663-8668
[2]   Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor [J].
Bladbjerg, EM ;
Skouby, SO ;
Andersen, LF ;
Jespersen, J .
HUMAN REPRODUCTION, 2002, 17 (12) :3235-3241
[3]   Different effect induced by treatment with several statins on monocyte tissue factor expression in hypercholesterolemic subjects [J].
Bruni, F ;
Puccetti, L ;
Pasqui, AL ;
Pastorelli, M ;
Bova, G ;
Cercignani, M ;
Palazzuoli, A ;
Leo, A ;
Auteri, A .
CLINICAL AND EXPERIMENTAL MEDICINE, 2003, 3 (01) :45-53
[4]   The hypercoagulable state of malignancy: Pathogenesis and current debate [J].
Caine, GJ ;
Stonelake, PS ;
Lip, GYH ;
Kehoe, ST .
NEOPLASIA, 2002, 4 (06) :465-473
[5]   Caveolae: Mining little caves for new cancer targets [J].
Carver, LA ;
Schnitzer, JE .
NATURE REVIEWS CANCER, 2003, 3 (08) :571-581
[6]   NORGESTREL AND GESTODENE STIMULATE BREAST-CANCER CELL-GROWTH THROUGH AN ESTROGEN-RECEPTOR MEDIATED MECHANISM [J].
CATHERINO, WH ;
JENG, MH ;
JORDAN, VC .
BRITISH JOURNAL OF CANCER, 1993, 67 (05) :945-952
[7]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[8]   Interferon-γ modulates prolactin and tissue factor expression in differentiating human endometrial stromal cells [J].
Christian, M ;
Marangos, P ;
Mak, I ;
McVey, J ;
Barker, F ;
White, J ;
Brosens, JJ .
ENDOCRINOLOGY, 2001, 142 (07) :3142-3151
[9]   HORMONAL-CONTROL OF PROLIFERATION IN THE ISHIKAWA ENDOMETRIAL ADENOCARCINOMA CELL-LINE [J].
CROXTALL, JD ;
ELDER, MG ;
WHITE, JO .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 35 (06) :665-669
[10]  
Dietzen DJ, 2003, THROMB HAEMOSTASIS, V89, P65